drugset
Drugs / Lactobacillus acidophilus NCFM
last change Dec 2007 re-read 3 minutes ago

Lactobacillus acidophilus NCFM

Other / unclassified

Developed for
type 2 diabetes mellitus
Investigated by
Rigshospitalet, Denmark · Royal Veterinary and Agricultural University, Denmark

Trials 1

today NCT00413348 · not/applicable
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00413348 Nov 2006 → Dec 2007 type 2 diabetes mellitus Rigshospitalet, Denmark Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lactobacillus acidophilus NCFM ClinicalTrials.gov intervention name — accepted as the source's own label NCT00413348 ↗
Modality Other / unclassified “In this study type 2 diabetics (N=24) and healthy control (N=24) are given the probiotic bacteria Lactobacillus Acidophilus NCFM for four weeks.” NCT00413348 ↗